ArticleExpert opinion on therapeutic patents2015

An evaluation of US patent 2015065565 (A1) for a new class of SGLT2 inhibitors for treatment 1 of type II diabetes mellitus.

Meiyan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.